Sato, M., Matsui, A., Shimoyama, Y., Omote, N., Morise, M., Hase, T., . . . Hasegawa, Y. (2018). An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib. Intern Med.
Παραπομπή Chicago StyleSato, Mitsuo, Akira Matsui, Yoshie Shimoyama, Norihito Omote, Masahiro Morise, Tetsunari Hase, Ichidai Tanaka, Kojiro Suzuki, και Yoshinori Hasegawa. "An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib." Intern Med 2018.
Παραπομπή MLASato, Mitsuo, et al. "An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib." Intern Med 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.